ArticlePediatric nephrology (Berlin, Germany)2026
Kidney function monitoring in pediatric sickle cell disease: evidence from the NEPHRODREPA study.
Article in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05211037 (Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSickle cell disease (SCD) induces early kidney abnormalities, beginning in childhood with glomerular hyperfiltration and progressing toward chronic kidney disease. Estimating glomerular filtration rate (GFR) in these patients remains challenging due to limitations of creatinine-based formulas. This study aimed to assess kidney function in children and young adults with SCD using isotopic GFR measurement and various estimation equations, including creatinine and cystatin C-based formulas.
methodsNEPHRODREPA is a prospective pilot study including 17 patients (age 4-21 years) followed at the University Hospital of Nice. In addition to the annual check-up, serum cystatin C and
resultsThe median GFR measured by
conclusionThis study suggests that in young patients with SCD without known nephropathy, the CKiDU25 equation using serum cystatin C, provides GFR estimates close to the gold standard isotopic measurement. Early tubular dysfunction is prevalent and may justify therapeutic interventions. These findings warrant confirmation in larger cohorts.
Indexed as
Identifiers
41484585What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.